Abstract:Background: Stromal fibrosis is highly associated with therapeutic resistance and poor survival in esophageal squamous cell carcinoma (ESCC) patients. Low expression of plasma gelsolin (pGSN), a serum abundant protein, has been found to correlate with inflammation and fibrosis. Here, we evaluated pGSN expression in patients with different stages of cancer and therapeutic responses, and delineated the molecular mechanisms involved to gain insight into therapeutic strategies for ESCC. Methods: Circulating pGSN level in ESCC patients was determined by enzyme-linked immunosorbent assay analysis, and the tissue microarray of tumors was analyzed by immunohistochemistry staining. Cell-based studies were performed to investigate cancer behaviors and molecular mechanisms, and mouse models were used to examine the pGSN-induced tumor suppressive effects in vivo. Results: Circulating pGSN expression is distinctively decreased during ESCC progression, and low pGSN expression correlates with poor therapeutic responses and poor survival. Methylation-specific PCR analysis confirmed that decreased pGSN expression is partly attributed to the hypermethylation of the GSN promoter, the gene encoding pGSN. Importantly, cell-based immunoprecipitation and protein stability assays demonstrated that pGSN competes with oncogenic tenascin-C (TNC) for the binding and degradation of integrin αvβ3, revealing that decreased pGSN expression leads to the promotion of oncogenic signaling transduction in cancer cells and fibroblasts. Furthermore, overexpression of pGSN caused the attenuation of TNC expression and inactivation of cancer-associated fibroblast (CAF), thereby leading to tumor growth inhibition in mice. Conclusions: Our results demonstrated that GSN methylation causes decreased secretion of pGSN, leading to integrin dysregulation, oncogenic TNC activation, and CAF formation. These findings highlight the role of pGSN in therapeutic resistance and the fibrotic tumor microenvironment of ESCC.

Gelsolin Regulates Proliferation, Apoptosis, Migration and Invasion in Human Oral Carcinoma Cells

Role of Gelsolin in Cell Proliferation and Invasion of Human Hepatocellular Carcinoma Cells.

Overexpression of Gelsolin Reduces the Proliferation and Invasion of Colon Carcinoma Cells

Gelsolin Regulates Proliferation, Apoptosis and Invasion in Natural Killer/t-Cell Lymphoma Cells

Gelsolin Promotes Cell Growth and Invasion Through the Upregulation of P-Akt and P-P38 Pathway in Osteosarcoma

The Effects of Gelsolin on the Proliferation and Migration of Human Dental Pulp Cells

Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers

3untranslated regions (3UTR) of <i>Gelsolin</i> mRNA displays anticancer effects in non-small cell lung cancer (NSCLC) cells

Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients

Identification of Low Expression of GSN as a Key Prognosis Gene in Patients with Gastric Carcinoma

Emerging roles of plasma gelsolin in tumorigenesis and modulating the tumor microenvironment

Downregulation of the Gnt-V Gene Inhibits Metastasis and Invasion of Bgc823 Gastric Cancer Cells

Regulation and Related Mechanism of GSN Mrna Level by Hnrnpk in Lung Adenocarcinoma Cells

Gelsolin-mediated Activation of PI3K/Akt Pathway is Crucial for Hepatocyte Growth Factor-Induced Cell Scattering in Gastric Carcinoma.

Decreased plasma gelsolin fosters a fibrotic tumor microenvironment and promotes chemoradiotherapy resistance in esophageal squamous cell carcinoma

Gelsolin knockdown confers radiosensitivity to glioblastoma cells

Concurrent Down-Regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells.

Regulation of the proliferation and motility of human glioblastoma cells by Girdin

Effects of Gekko Sulfated Polysaccharide–protein Complex on Human Hepatoma SMMC-7721 Cells: Inhibition of Proliferation and Migration

Effect of GPNMB on proliferation and invasion of oral squamous cell carcinoma cells

Effect of the Regulator of G-protein Signaling 2 on the Proliferation and Invasion of Oral Squamous Cell Carcinoma Cells and Its Molecular Mechanism.